close
close
  • February 11, 2025
Honey Biotech shareholders shocked by liquidation attempt

Honey Biotech shareholders shocked by liquidation attempt

The founder of TRG Natural Pharmaceuticals files to liquidate the company, much to the surprise of small shareholders.

TRG Natural Pharmaceuticals develops medical products for skin conditions, pain, nutrition and cosmetics from kanuka honey.

Shareholders of honey biotech company TRG Natural Pharmaceuticals are looking for answers as the company’s founder and second-largest investor tries to liquidate the company.

A message that appeared in the Gazette on December 3, Shaun Holt said he had filed an application to appoint liquidators in the

Read more? It’s easy.

Choose your most affordable subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).

Individually

Group membership

NBR marketplace

Annual Premium Online Subscription

€499.00 / yearly

Monthly Premium Online Subscription

€44.95 / month

Smartphone subscription only

€24.95 / month

Premium group membership 10 users

NZ$350+ VAT / monthly

$35 per user – Pay via monthly credit card bill

Premium group membership 20 users

NZ$600+ VAT / monthly

$30 per user – Pay per monthly credit card charge

Premium group membership 50 users

NZ$1250+ VAT / monthly

$25 per user – Pay per monthly credit card charge

Premium group membership 100 users

NZ$1875+ VAT / monthly

$18.75 per user – Pay via monthly credit card bill

Annual Premium Online Subscription + NBR Marketplace

€499.00 / yearly

Do you already have an account? Login

© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.